Venus Medtech (Hangzhou) (2500.HK) Earnings Analysis

Venus Medtech (Hangzhou) (2500.HK) next reports earnings on 2026-08-27. Last quarter (2026-03-31) it missed with EPS -0.68975 HKD vs -0.33386 HKD est (-106.6%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -1.11.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 2500.HK next report earnings?

Next earnings date2026-08-27
Consensus EPS estimaten/a
Revenue estimaten/a

2500.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-31-0.68975 HKD-0.33386 HKD-106.6%Miss
2025-08-28-0.33673 HKD-0.38353 HKD+12.2%Beat
2024-08-30-0.50639 HKD-0.44052 HKD-15%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

2500.HK valuation and analyst view

Trailing P/E-1.11
Trailing EPS-0.93102 HKD
Price / book0.26
Dividend yield0.00%
Market cap0.54B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Venus Medtech (Hangzhou) (2500.HK)'s next earnings date?

Venus Medtech (Hangzhou) is next scheduled to report on 2026-08-27.

Did 2500.HK beat earnings last quarter?

In its 2026-03-31 report, 2500.HK posted EPS of -0.68975 HKD versus a -0.33386 HKD estimate — a miss of 106.6%.

What is 2500.HK's earnings track record?

Over the last 3 reported quarters with consensus data, 2500.HK beat estimates 1 times (33%).

What is 2500.HK's current P/E ratio and EPS?

2500.HK trades at a trailing P/E of -1.11 on trailing EPS of -0.9310235766506614 HKD.

What do analysts rate 2500.HK?

2500.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.